Rationality Analysis of Inhaled Medication for Pediatric Bronchopneumonia Based on Children Drug Utilization Index

Jiang Junfei; Gao Yue; Liu Chong

doi:10.13407/j.cnki.jpp.1672-108X.2023.04.003

您当前的位置：

首页 >

文章列表页 >

Rationality Analysis of Inhaled Medication for Pediatric Bronchopneumonia Based on Children Drug Utilization Index

更新时间：2023-04-28

- Rationality Analysis of Inhaled Medication for Pediatric Bronchopneumonia Based on Children Drug Utilization Index
- Vol. 29, Issue 4, Pages: 11-13(2023)
- 作者机构：
  
  上海市松江区中心医院,上海,201600
- 作者简介：
- 基金信息：
- DOI：10.13407/j.cnki.jpp.1672-108X.2023.04.003
  CLC：
- Published：2023，
扫描看全文
Jiang Junfei, Gao Yue, Liu Chong. Rationality Analysis of Inhaled Medication for Pediatric Bronchopneumonia Based on Children Drug Utilization Index. [J]. 29(4):11-13(2023)
DOI：

Jiang Junfei, Gao Yue, Liu Chong. Rationality Analysis of Inhaled Medication for Pediatric Bronchopneumonia Based on Children Drug Utilization Index. [J]. 29(4):11-13(2023) DOI： 10.13407/j.cnki.jpp.1672-108X.2023.04.003.

摘要

目的:采用儿童药物利用指数(cDUI)评价松江区中心医院儿科支气管肺炎吸入药物合理用药情况。方法:采用回顾性研究方法分析上海市松江区中心医院2018-2021 年儿科诊断为支气管肺炎的1 493 例住院患儿资料

提取其中使用吸入用布地奈德混悬液或硫酸特布他林雾化液的病例(共1 331 例)并计算cDUI。结果:吸入用布地奈德混悬液的cDUI 为2. 79

硫酸特布他林雾化液的cDUI 分别为>20 kg 组0. 25、≤20 kg 组为0. 50。结论:通过cDUI 评价儿科支气管肺炎在应用吸入用布地奈德混悬液及硫酸特布他林雾化液方面存在不合理现象

问题主要集中在用药剂量、使用频次及适应证方面

临床需引起重视。

Abstract

Objective: To evaluate the rational application of inhalant drugs in the treatment of pediatric bronchopneumonia in Songjiang District Central Hospital by using children drug utilization index (cDUI). Methods: A retrospective study was utilized to analyze the data of 1

493 hospitalized children discharged from Pediatrics Department in Songjiang District Central Hospital from 2018 to 2021

and the cDUI values of inhaled budesonide suspension or terbutaline sulfate atomized solution were extracted and calculated. Results: The cDUI of budesonide suspension for inhalation was 2. 79

and that of terbutaline sulfate atomized solution was 0. 25 in > 20 kg group

and 0. 50 in ⩽ 20 kg group respectively. Conclusion: There are a lot unreasonable phenomena in the application of inhaled budesonide suspension and terbutaline sulfate aerosol in the evaluation of bronchopneumonia by cDUI. The problems mainly concentrate on the dosage

frequency of use and indications

which needs attention in clinical application.

关键词

儿童药物利用指数支气管肺炎布地奈德混悬液硫酸特布他林雾化液

Keywords

children drug utilization indexbronchopneumoniabudesonide suspensionterbutaline sulfate atomized solution

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Rational Application of Ribonucleic Acid for Injection Ⅱ in Children

Molecular Mechanism of Ephedra Herba and Amygdalus Communis Vas Couplet Medicines in the Treatment of Bronchopneumonia Based on Network Pharmacology

Related Author

An Na

Zhang Guying

Jia Chenhong

Ding Xiangyu

Liu Yanhui

Li Ruihong

Xue Meng

Yan Meixing

Related Institution

Children’s Hospital of Hebei Province

Qingdao Women and Children’s Hospital

⁰